Evidence map›Paper›PMID 38963827›Full record

ArticleThe Journal of infectious diseases2025

Genomic Epidemiology and Evolution of Rhinovirus in Western Washington State, 2021-2022.

Stephanie Goya, Seffir T Wendm, Hong Xie, Tien V Nguyen, Sarina Barnes, Rohit R Shankar, Jaydee Sereewit, Kurtis Cruz, Ailyn C Pérez-Osorio, Margaret G Mills and 1 more

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Recovery of an 18bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Automated annotation and validation of human respiratory virus sequences using VADR.Database : the journal of biological databases and curation · 2025
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Stephanie GoyaDepartment of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington.ORCID 0000-0001-7479-3064
Seffir T WendmDepartment of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington.
Hong XieDepartment of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington.
Tien V NguyenDepartment of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington.
Sarina BarnesDepartment of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington.
Rohit R ShankarDepartment of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington.
Jaydee SereewitDepartment of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington.
Kurtis CruzDepartment of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington.
Ailyn C Pérez-OsorioDepartment of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington.
Margaret G MillsDepartment of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington.
Alexander L GreningerDepartment of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington.ORCID 0000-0002-7443-0527

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuman rhinoviruses (RVs) primarily cause the common cold, but infection outcomes vary from subclinical to severe cases, including asthma exacerbations and fatal pneumonia in individuals who are immunocompromised. To date, therapeutic strategies have been hindered by the high diversity of serotypes. Global surveillance efforts have traditionally focused on sequencing VP1 or VP2/VP4 genetic regions, leaving gaps in our understanding of RV genomic diversity.

methodsWe sequenced 1078 RV genomes from nasal swabs of symptomatic and asymptomatic individuals to explore viral evolution during 2 epidemiologically distinct periods in Washington State: when the COVID-19 pandemic affected the circulation of other seasonal respiratory viruses except for RV (February-July 2021) and when the seasonal viruses reemerged with the severe outbreak of respiratory syncytial virus and influenza (November-December 2022). We constructed maximum likelihood and BEAST phylodynamic trees to characterize intragenotype evolution.

resultsWe detected 99 of 168 known genotypes and observed intergenotypic recombination and genotype cluster swapping from 2021 to 2022. We found a significant association between the presence of symptoms and viral load but not with RV species or genotype. Phylodynamic trees, polyprotein selection pressure, and Shannon entropy revealed cocirculation of divergent clades within genotypes with high amino acid constraints throughout the polyprotein.

conclusionsOur study underscores the dynamic nature of RV genomic epidemiology within a localized geographic region, as >20% of existing genotypes within each RV species cocirculated each studied month. Our findings also emphasize the importance of investigating correlations between RV genotypes and serotypes to understand long-term immunity and cross-protection.

Indexed as

Evolution, MolecularGenome, ViralPicornaviridae InfectionsRhinovirusCOVID-19GenomicsGenotypeHumansMolecular EpidemiologyPhylogenyWashingtongenomic epidemiologyrhinovirusviral evolutionVP1Washington

Identifiers

PMID38963827
PMCPMC11793040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.